"Etoposide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A semisynthetic derivative of PODOPHYLLOTOXIN that exhibits antitumor activity. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent entry into the mitotic phase of cell division, and lead to cell death. Etoposide acts primarily in the G2 and S phases of the cell cycle.
- Demethyl Epipodophyllotoxin Ethylidine Glucoside
- Tedec Meiji Brand of Etoposide
- Pharmachemie Brand of Etoposide
- Medac Brand of Etoposide
- Eto GRY
- Gry Brand of Etoposide
- Lemery Brand of Etoposide
- Baxter Oncology Brand of Etoposide
- Sanfer Brand of Etoposide
- Prasfarma Brand of Etoposide
- Onkoworks Brand of Etoposide
- ribosepharm Brand of Etoposide
- Teva Brand of Etoposide
- Etoposide Teva
- Bristol-Myers Squibb Brand of Etoposide
- Bristol Myers Squibb Brand of Etoposide
- Bristol-Myers Brand of Etoposide
- Bristol Myers Brand of Etoposide
- Baxter Brand of Etoposide
Below are MeSH descriptors whose meaning is more general than "Etoposide".
Below are MeSH descriptors whose meaning is more specific than "Etoposide".
This graph shows the total number of publications written about "Etoposide" by people in the URMC Research Network by year, and whether "Etoposide" was a major or minor topic of these publication.